• Board-certified – Cytopathology and Anatomic and Clinical Pathology by the American Board of Pathology
  • Fellowship – Cytopathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
  • Residency – Anatomic and Clinical Pathology, University of Maryland Medical Center, Baltimore, MD
  • Medical School – Johns Hopkins School of Medicine, Baltimore, MD
  • Dr. Xu has published 35 peer-reviewed articles and abstracts. She is the ProPath Medical Director at Medical City Weatherford.
  • Joined ProPath  in 2016

Peer-Reviewed Articles

  1. Staats P, Kligerman S, Todd N, Tavora F, Xu L, Burke A. A comparative study of honeycombing on high resolution computed tomography with histologic lung remodeling in explants with usual interstitial pneumonia. Pathol Res Pract. 2015;211(1):55-61.
  2. Xu L, Heath J, Burke A. Ascending aortitis: a clinicopathological study of 21 cases in a series of 300 aortic repairs. Pathology. 2014;46(4):296-305.
  3. Xu L, Collins J, Drachenberg C, Kukuruga D, Burke A. Increased macrophage density of cardiac allograft biopsies is associated with antibody-mediated rejection and alloantibodies to HLA antigens. Clin Transplant. 2014;28(5):554-560.
  4. Xu L, Kligerman S, Nevins T, Burke A. Pulmonary sarcoidosis: necrotizing granulomas on explant, with recurrence on surveillance biopsies. Pathol Case Rev. 2013;18(3):138-143.
  5. Xu L, Burke A. Acute medial dissection of the ascending aorta: evolution of reactive histologic changes.  Am J Surg Pathol. 2013;37(8):1275-1282.
  6. Xu L, Tavora F, Burke A. Histologic features associated with metastatic potential in invasive adenocarcinomas of the lung. Am J Surg Pathol. 2013;37(7):1100-1108.
  7. Xu L, Kligerman S, Burke A. End-stage sarcoid lung disease is distinct from usual interstitial pneumonia. Am J Surg Pathol. 2013;37(4):593-600.
  8. Xu L, Drachenberg C, Tavora F, Burke A. Histologic findings in lung biopsies in patients with suspected  graft-versus-host disease. Hum Pathol. 2013;44(7):1233-1240.
  9. Xu L, Frazier A, Burke A. Isolated pulmonary amyloidomas: report of 3 cases with histologic and imaging findings. Pathol Res Pract. 2013;209(1):62-66.
  10. Xu L, Burke A. Pulmonary metastasis from a low grade mucinous appendiceal neoplasm. Pathology. 2013;45(2):186-188.
  11. Xu L, Jeudy J, Burke AP. Ectopic hepatic tissue presenting as right atrial mass. Hum Pathol. 2012;43(6):958-960.
  12. Xu L, Tavora F, Burke A. “Bronchioloalveolar carcinoma”: is the term really dead? A critical review of a new classification system for pulmonary adenocarcinomas. Pathology. 2012;44(6):497-505.
  13. Xu L, Tavora F, Battafarano R, Burke A. Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society. Am J Surg Pathol. 2012;36(2):273-282.
  14. Xu L, Burke A. Pulmonary oligometastases: histological features and difficulties in determining site of origin. Int J Surg Pathol. 2012;20(6):577-588.
  15. Xu L, Drachenberg C, Burke A. Intimal IgM lambda paraprotein deposition in myocardial arteries resulting in acute myocardial infarction and sudden death. Pathology. 2011;43(7):732-734.
  16. Alexiev BA, Xu L, Heath JE, Twaddell WS, Phelan MW. Adenomatoid tumor of the testis with intratesticular growth: a case report and review of the literature. Int J Surg Pathol. 2011;19(6):838-842.
  17. Sfanos KS, Bruno TC, Maris CH, Xu L, Thoburn C, Demarzo A, Meeker A, Isaacs W, Drake C. Phenotypic analysis of prostate-infiltrating lymphocytes reveals T H17 and Treg skewing. Clin Cancer Res. 2008;14(11):3254-3261.
  18. Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, Meyers J, Leitch CC, Katsanis N, Sharifi N, Xu L, Myers LA, Spevak PJ, Cameron DE, De Backer J, Hellemans J, Chen Y, Davis EC, Webb CL, Kress W, Coucke P, Rifkin DB, De Paepe AM, Dietz HC. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet. 2005;37(3):275-281.


  1. Xu L, Drachenberg C, Iacono A, Burke A. Histological characterization of pulmonary transplant patients with donor specific antibodies and those without (platform presentation). International Society for Heart and Lung transplantation (ISHLT) Annual Meeting, 2013. J Heart Lung Transplant. 2013;32(4)(suppl):S19.
  2. Xu L, Drachenberg C, Iacono A, Burke A. Pathologic findings in explanted pulmonary allografts. J Heart Lung Transplant. 2013;32(4)(suppl):S245.
  3. Xu L, Burke A, Feigenberg S. Correlation between grade and histological subtype of pulmonary adenocarcinoma and [18F] fluorodeoxyglucose standardized uptake value after evaluation by PET/CT (platform presentation, B-0023). ECR Annual Meeting SS104, 2013.
  4. Xu L, Burke A. Histopathologic findings in grossly normal areas of lungs explanted for idiopathic pulmonary fibrosis. ATS Annual Meeting, 2013.
  5. Xu L, Huebner T, Tavora F, Burke A. Application of the IASLC/ATS/ERS classification of lung adenocarcinomas and implications for tumor grading [abstract 1956]. Mod Pathol. 2013;26(suppl 2s).
  6. Xu L, Goicochea L, Tavora F, Burke A. Incidental ascending aortitis: the histologic and clinical spectrum [abstract 331]. Mod Pathol. 2013;26(suppl 2s):81A.
  7. Xu L, Kligerman S, Burke A. Honeycombing in idiopathic pulmonary fibrosis: pathology and imaging correlations [abstract 1957]. Mod Pathol. 2013;26(suppl 2s):470A.
  8. Xu L, Kligerman S, Burke Honeycombing in idiopathic pulmonary fibrosis: pathology vs. imaging.  ATS Annual Meeting, 2012.
  9. Xu L, Drachenberg C, Feller E, Burke A. Serological characterization of cardiac transplant patient with evidence of antibody mediated rejection and those without. J Heart Lung Transplant. 2012;31(4)(suppl):S164.
  10. Xu L, Drachenberg C, Feller E, Burke A. Macrophage density of cardiac allograft biopsies reflects complement staining by C4d and is strongly associated with alloantibodies to HLA antigens (platform presentation).  J Heart Lung Transplant. 2012;31(4)(suppl):S43.
  11. Xu L, Miller C, Burke AP. Pathological features of adventitial inflammatory reaction in acute aortic dissections [abstract 329]. Mod Pathol. 2012;25(suppl 2s):81A.
  12. Xu L, Drachenberg C, Britt EJ, Burke AP. Pathological findings in lung biopsies in patients with clinical suspicion of pulmonary graft versus host disease [abstract 2054]. Mod Pathol. 2012;25(suppl 2s):492A-493A.
  13. Xu L, Phillips D, Sun C. Abdominal cocoon and diffuse meconium peritonitis in fetal hydrops. Arch Pathol Lab Med. 2011;135(9):1172.
  14. Xu L, Burke A. Pathology of pulmonary oligometastases. Arch Pathol Lab Med. 2011;135(9):1209.
  15. Xu L, Battafarano R, BurrowsW, Burke A. The significance of minimally invasive adenocarcinoma in the classification of pulmonary tumors [abstract 1821]. Mod Pathol. 2011;24(suppl 1s):428A.
  16. Heath JE, Xu LF, Burke AP. Primary sarcoma of the aorta and lower extremity arteries: an analysis of 26 cases [abstract 306]. Mod Pathol. 2011;24(suppl 1s):74A.
  17. Zhang R, Xu L, Li L, Oliveira B, Burke A. Novel PKP2 mutations in sudden death due to arrhythmogenic right ventricular cardiomyopathy and sudden unexpected death with normal cardiac morphology [abstract 327A, platform presentation]. USCAP Meeting, 2011. Mod Pathol. 2011;24(suppl 1s).

Meet Our Experts

ProPath is an internationally recognized practice of academic-quality expertise with private practices.